InfuSystem Holdings (INFU) Other Non-Current Assets (2010 - 2026)
InfuSystem Holdings (INFU) posted Other Non-Current Assets of $1.6 million for Q1 2026, down 1.91% on a QoQ basis from $1.7 million in Q4 2025, and up 175.71% year-over-year from $597000.0 in Q1 2025.
InfuSystem Holdings (INFU) Other Non-Current Assets (2010 - 2026) Analysis & Trends
InfuSystem Holdings' Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $1.6 million for Q1 2026.
- Quarterly Other Non-Current Assets rose 175.71% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (up 175.71% YoY) and the FY2025 annual result came in at $1.7 million, up 91.12% from the prior year.
- Other Non-Current Assets was $1.6 million for Q1 2026 at InfuSystem Holdings, down from $1.7 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $2.2 million in Q3 2022 and bottomed at $80000.0 in Q4 2022.
- A 5-year average of $1.2 million and a median of $1.3 million in 2024 frame the typical range for Other Non-Current Assets.
- Peak annual rise in Other Non-Current Assets reached 1876.25% in 2023, while the deepest fall reached 69.2% in 2023.
- InfuSystem Holdings' Other Non-Current Assets stood at $80000.0 in 2022, then jumped by 1876.25% to $1.6 million in 2023, then tumbled by 44.47% to $878000.0 in 2024, then jumped by 91.12% to $1.7 million in 2025, then decreased by 1.91% to $1.6 million in 2026.
- Business Quant data shows INFU's Other Non-Current Assets at $1.6 million in Q1 2026, $1.7 million in Q4 2025, and $499000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.05 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 285.90 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 828.89 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 164.00 Mn |
| 10 | InfuSystem Holdings | 179.47 Mn | 177.37 Mn | 19.68 Mn | 1.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.65 Mn |
| Dec 31, 2025 | 1.68 Mn |
| Sep 30, 2025 | 499,000.00 |
| Jun 30, 2025 | 432,000.00 |
| Mar 31, 2025 | 597,000.00 |
| Dec 31, 2024 | 878,000.00 |
| Sep 30, 2024 | 1.01 Mn |
| Jun 30, 2024 | 1.33 Mn |
| Mar 31, 2024 | 1.59 Mn |
| Dec 31, 2023 | 1.58 Mn |
| Sep 30, 2023 | 1.76 Mn |
| Jun 30, 2023 | 1.22 Mn |
| Mar 31, 2023 | 425,000.00 |
| Dec 31, 2022 | 80,000.00 |
| Sep 30, 2022 | 2.18 Mn |
| Jun 30, 2022 | 1.56 Mn |
| Mar 31, 2022 | 1.38 Mn |
| Dec 31, 2021 | 116,000.00 |
| Sep 30, 2021 | 207,000.00 |
| Jun 30, 2021 | 169,000.00 |